Get the Stockscreener App
16.18
0.73%
0.3916
Vtv Therapeutics Inc stock is traded at $16.18, with a volume of 1,509.
It is up +0.73% in the last 24 hours and up +2.35% over the past month.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
See More
Previous Close:
$15.79
Open:
$16.09
24h Volume:
1,509
Relative Volume:
0.31
Market Cap:
$42.14M
Revenue:
$5.02M
Net Income/Loss:
$-18.31M
P/E Ratio:
-3.5721
EPS:
-4.53
Net Cash Flow:
$-23.40M
1W Performance:
+6.03%
1M Performance:
+2.35%
6M Performance:
-13.56%
1Y Performance:
-4.36%
1-Day Range:
$16.06
$16.10
1-Week Range:
$14.55
$16.10
52-Week Range:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
16.10 | 41.88M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.32 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.52 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.13 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.26 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
298.71 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
Pattern recognition hints at vTv Therapeutics Inc. upsideJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser
Will vTv Therapeutics Inc. stock recover after recent dropTrade Risk Report & Smart Swing Trading Techniques - Newser
vTv Therapeutics Inc. stock trend outlook and recovery pathEarnings Growth Summary & Free Verified High Yield Trade Plans - Newser
What earnings revisions data tells us about vTv Therapeutics Inc.2025 Volatility Report & Weekly High Return Opportunities - Newser
Will vTv Therapeutics Inc. stock go up soonPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - Newser
Chart based analysis of vTv Therapeutics Inc. trendsNew Guidance & Smart Allocation Stock Reports - Newser
vTv Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
What MACD and RSI say about vTv Therapeutics Inc.July 2025 Decliners & Accurate Technical Buy Alerts - Newser
vTv Therapeutics Inc. Stock Poised for Technical Comeback getLinesFromResByArray error: size == 0 - newsyoung.net
Will a bounce in vTv Therapeutics Inc. offer an exitTrade Risk Assessment & Free High Return Stock Watch Alerts - Newser
What to do if you’re stuck in vTv Therapeutics Inc.2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Is vTv Therapeutics Inc. stock overvalued or fairly priced2025 AllTime Highs & Short-Term Trading Opportunity Alerts - sundaytimes.kr
vTv Therapeutics Inc. Attempts Reversal From Key SupportTrade Entry Report & Real-Time Market Sentiment Reports - 더경남뉴스
How to monitor vTv Therapeutics Inc. with trend dashboardsPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
Should you hold or exit vTv Therapeutics Inc. nowTrade Ideas & Fast Moving Stock Watchlists - Newser
Can trapped investors hope for a rebound in vTv Therapeutics Inc.Weekly Investment Summary & High Accuracy Swing Trade Signals - Newser
What makes vTv Therapeutics Inc. stock price move sharplyWall Street Watch & Weekly Consistent Profit Watchlists - Newser
How Resilient Is vTv Therapeutics Inc. Stock During Economic DownturnsRisk Management & Low Risk High Win Rate Picks - Newser
vTv Therapeutics Inc. Stock Poised for Technical ComebackJuly 2025 Opening Moves & Fast Entry High Yield Tips - 더경남뉴스
vTv Therapeutics Inc. Stock Support and Resistance Levels You Should Know2025 Growth vs Value & Fast Gain Stock Trading Tips - Newser
Smart tools for monitoring vTv Therapeutics Inc.’s price actionWeekly Investment Report & Weekly High Conviction Ideas - Newser
What machine learning models say about vTv Therapeutics Inc.2025 Market Sentiment & Smart Investment Allocation Tips - Newser
How to build a custom watchlist for vTv Therapeutics Inc.July 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
How vTv Therapeutics Inc. stock performs during market volatilityJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
vTv Therapeutics Inc. stock daily chart insightsMarket Movement Recap & Long Hold Capital Preservation Plans - Newser
Custom strategy builders for tracking vTv Therapeutics Inc.Portfolio Return Summary & Capital Protection Trade Alerts - Newser
Is vTv Therapeutics Inc. trending in predictive chart modelsJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
Does vTv Therapeutics Inc. fit your quant trading modelQuarterly Trade Report & Precise Swing Trade Alerts - Newser
vTv Therapeutics Inc. stock retracement – recovery analysisDay Trade & Low Risk Investment Opportunities - Newser
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
7.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):